Article
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Nature communications - 11 Jul 2024
Forrest Suzanne J, Gupta Hersh, Ward Abigail, Li Yvonne Y, Doan Duong, Al-Ibraheemi Alyaa, Alexandrescu Sanda, Bandopadhayay Pratiti, Shusterman Suzanne, Mullen Elizabeth A, Collins Natalie B, Chi Susan N, Wright Karen D, Kumari Priti, Mazor Tali, Ligon Keith L, Shivdasani Priyanka, Manam Monica, MacConaill Laura E, Ceca Evelina, Benich Sidney N, London Wendy B, Schilsky Richard L, Bruinooge Suanna S, Guidry Auvil Jaime M, Cerami Ethan, Rollins Barrett J, Meyerson Matthew L, Lindeman Neal I, Johnson Bruce E, Cherniack Andrew D, Church Alanna J, Janeway Katherine A
Abstract excerpt
To inform clinical trial design and real-world precision pediatric oncology practice, we classified diagnoses, assessed the landscape of mutations, and identified genomic variants matching trials in a large unselected institutional cohort of solid tumors patients sequenced at Dana-Farber / Boston Children's Cancer and Blood Disorders Center. Tumors were sequenced with OncoPanel, a targeted next-generation DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
